title: Effect of naloxone on maximal exercise performance and control of ventilation in COPD.
abstract: Elevated endorphin levels in patients with COPD may act to diminish the sensation of dyspnea. Exogenous opioids decrease exertional dyspnea and increase exercise capacity in COPD patients. The purpose of this study was to determine the effects of endogenous opioids on the exercise capacity and control of breathing in patients with COPD. We hypothesized that naloxone, an opioid antagonist, would block the endogenous endorphins and decrease the exercise capacity of our patients. Six patients (mean age, 58.8 +/- 3.2 years) with COPD (mean FEV1, 1.28 +/- 0.46 L) underwent identical incremental cycle ergometer tests to exhaustion (Emax) and assessment of their hypercapnic and hypoxic ventilatory responses and mouth occlusion pressure responses following the IV administration of naloxone (0.4 mg/kg) (N) or placebo (P) in a randomized, double-blind fashion. Perceived dyspnea (modified Borg scale), breathing patterns, and expired gas levels were compared at rest and at maximal workload (WL). There was no significant difference after N compared with after P in the WL or the duration of work. At Emax there were no significant differences after N compared with after P in ventilation, the level of dyspnea, P0.1, VO2, or VCO2. The ventilatory response to CO2 production during exercise (delta VE/delta VCO2) and the ventilatory and mouth occlusion pressure responses to hypoxia and hypercapnia did not differ significantly after N compared with after P. This study does not support the hypothesis that endogenous opioids play a significant role in dampening dyspnea and facilitating exercise in patients with COPD.
authors.affiliation: Department of Medicine, VA Medical Center, Long Beach.
authors.forename: J L
authors.initials: JL
authors.lastname: Kirsch
authors.forename: J R
authors.initials: JR
authors.lastname: Muro
authors.forename: D W
authors.initials: DW
authors.lastname: Stansbury
authors.forename: C E
authors.initials: CE
authors.lastname: Fischer
authors.forename: R
authors.initials: R
authors.lastname: Monfore
authors.forename: R W
authors.initials: RW
authors.lastname: Light
mesh_terms: D004311:Double-Blind Method; D004723:Endorphins / Q000502:physiology*; D015444:Exercise; D005080:Exercise Test; D005541:Forced Expiratory Volume; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D009270:Naloxone; D016032:Randomized Controlled Trials as Topic; D012119:Respiration / Q000187:drug effects*
chemical_list: D004723:Endorphins; D009270:Naloxone